5-HT reuptake inhibitors (Lilly)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name5-HT reuptake inhibitors (Lilly)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitors
TargetsSerotonin transporter
Therapy Area/IndicationsSchizophreniaPsychotic DisordersFeeding and Eating Disorders +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsSchizophreniaPsychotic DisordersFeeding and Eating Disorders +[4] 

Other Information

ATC CodeN/A
Related LinksN/A